Lots to like on this investor presentation. Trial results expected by June 2022 as mentioned in Bob's Presentation 14:15 mark. -
R&D incentive of ~$2.5 million expected in Q2 CY 2022 which will largely offset one quarter's spend and allow them 3 quarters before going for a capital raise.
